Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
It was originally approved for the treatment of type 2 diabetes by the FDA in May 2022 under the brand name Mounjaro, and then, in response to the significant weight loss results during clinical trials, the FDA approved tirzepatide in November 2023 for chronic weight management under the name Zepbound
Causes of Obesity: There are many causes of obesity, including genetics, overeating, and lack of exercise
HepatoCORE supports liver function, fat metabolism, and cardiovascular health
However, effectiveness varies between individuals, and it is not a substitute for lifestyle changes
US$ 29.57
US$ 29.25
US$ 28.95
US$ 29.19
US$ 24.25
US$ 23.91
